US Edition
Astellas Enhances Operations Across Ireland with €129 Million Investment in New Projects in Kerry and Dublin | Manufacturing & Supply Chain
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Astellas enhances operations across Ireland with €129 million investment in new projects in Kerry and Dublin | Manufacturing & Supply Chain
IDA Ireland has welcomed the commitment by Astellas, one of Japan’s largest life sciences companies and a leading developer and manufacturer of pharmaceutical products globally, to deliver a series of significant investments across its Irish operations. These investments, amounting to a total of €129 million, over the next three years, reinforce the company’s long-term commitment to Ireland as a strategic hub for its global manufacturing, resear…
Prostate cancer is the most common tumor among men in Spain, with 32,188 new cases estimated in 2025. Despite its high incidence, this type of tumor has one of the highest survival rates: 122,025 men live in Spain after being diagnosed in the last five years, a figure that shows how early detection and advances in treatments are allowing more and more patients to overcome the disease or live with it longer and with higher quality of life. Aware …
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
